AMCP is your partner in navigating AI’s transformative potential—ensuring patient-centered, ethically sound, and strategically aligned implementation across pharmacy practice and policy.
JMCP Outserts - Roadmap to Preventing Blindness: Managed Care Guide to Improve Outcomes for Retinal Diseases
FINDINGS FROM THE AMCP MARKET INSIGHTS PROGRAM | April, 2025
Summary
Retinal diseases in patients with diabetes pose signi cant challenges for health care systems. With a high treatment burden and advances in durable therapies, managed care organizations can optimize patient care by addressing coverage barriers that impact timely treatment with anti-VEGF therapies. This roadmap outlines essential points to better retinal disease management and improve treatment for populations of patients with diabetes at high risk for blindness.
For more disease state research, view the Market Insights Program.
Related
View our webinar on Managed Care Approaches to Address Unmet Patient Needs in Multiple Sclerosis (MS), a disease affecting nearly 1 million people in the U.S. Despite advancements in treatment, significant gaps remain in access, affordability, and comprehensive care.
Hemophilia is a disorder where the blood does not clot properly. This is due to the body not having enough blood-clotting proteins. This can lead to spontaneous bleeding as well as bleeding following injuries or surgery. They are two types of hemophilia. Hemophilia A and Hemophilia B. Hemophilia A is caused by the lack of low level or clotting factor VIII. Hemophilia B is caused by the lack or low level of clotting factor IX.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
